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Abstract
Nonatherosclerotic peripheral artery disease (NAPAD) remains underappreciated 
compared to atherosclerotic peripheral artery disease. However, under‐ or misdiag‐
nosis of NAPAD can potentially lead to serious adverse outcomes. There is a broad 
spectrum of disorders including vasculitis, thrombophilia, and other vascular ana‐
tomical or functional disorders in the context of NAPAD. This section briefly over‐
views vascular imaging, mainly invasive angiography, to optimize the management 
of NAPAD.
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1. Introduction
Nonatherosclerotic peripheral artery disease (NAPAD) remains underappreciated com‐
pared to atherosclerotic peripheral artery disease (APAD) due to its low prevalence. 
Despite common symptoms such as claudication, rest pain, and tissue loss, most clinicians 
are unfamiliar with the diagnosis of NAPAD. NAPAD should be suspected clinically in 
younger patients, and in older patients with few atherosclerotic risk factors, few athero‐
sclerotic features, or unusual lesion distributions. There is a broad spectrum of pathophysi‐
ologies in NAPAD, with the most common being arterial wall abnormalities, abnormal 
external and internal forces, spasm, vasculitis, and thrombophilia [1]. Under‐ or misdiag‐
nosis of NAPAD can lead to serious adverse outcomes that, with awareness of its distinc‐
tive symptoms and signs, may be avoided or minimized [2–5]. Thus, this section briefly 
overviews vascular imaging, mainly invasive angiography, to optimize the management 
of NAPAD.
© 2017 The Author(s). Licensee InTech. Distributed under the terms of the Creative Commons Attribution-
NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution
and reproduction for non-commercial purposes, provided the original is properly cited.
2. Workup for differential diagnosis
When there is a high clinical index of suspicion of NAPAD, the combination of blood exami‐
nation (biochemical and serological tests) and vascular imaging is an integral part of the dif‐
ferential diagnosis process (Figure 1).
In combination with vascular imaging, the assessment of macrocirculation by the ankle‐
brachial index is important. Furthermore, in regard to microcirculation assessment, either 
skin perfusion pressure (SPP) or transcutaneous oxygen pressure (TcPO
2
) can be applied in 
patients with critically ischemic limbs. Limb ischemia in younger patients warrants a high 
clinical suspicion of NAPAD. Even in older patients, most cases of NAPAD may be underdi‐
agnosed or misinterpreted as an atherosclerotic condition.
3. Arterial wall abnormalities
3.1. Fibromuscular dysplasia
Fibromuscular dysplasia (FMD) is a noninflammatory disease that produces arterial nar‐
rowing, aneurysms, dissection, and occlusion. Although the cause is unknown, 90% of cases 
occur in females [6], most frequently in the renal and carotid arteries, followed by the mesen‐
teric artery. Although lower extremity arteries are less commonly affected, FMD is one of the 
most significant causes of NAPAD [4, 7]. Pathologically, FMD can mainly be classified into 
three types, that is, intimal, medial, and perimedial. Angiographic classification identifies the 
multifocal type with multiple stenoses and the so‐called “string‐of‐beads” appearance, the 
tubular type, and the focal type. The “string‐of‐beads” sign that is frequently associated with 
the medial type is the most indicative of FMD, while the tubular and focal types may mimic 
atherosclerotic lesions [8] (Figure 2).
Figure 1. Approach to diagnosis of nonatherosclerotic peripheral artery disease.
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There are isolated reports of FMD mimicking vasculitis such as polyarteritis nodosa, 
Takayasu's arteritis (TA), and other disorders such as Ehlers‐Danlos's syndrome, Alport's syn‐
drome, and pheochromocytoma [9].
3.2. Adventitial cystic disease
Adventitial cystic disease is characterized by a collection of mucin in the adventitial layer, 
typically in the popliteal artery. In rare cases, the external iliac artery or femoral artery can be 
affected. This disorder is typically observed in middle‐aged persons, with a male‐to‐female 
ratio of 5–15:1 [4, 10]. Duplex ultrasound is considered a reasonable first‐line method to 
diagnose adventitial cystic disease. Although stenotic lesions may develop into occlusion, 
the angiographic findings show a smooth, eccentric, and extrinsically narrowed appearance 
(Figure 3).
3.3. Midaortic syndrome
Coarctation of the aorta is mostly located just distal to ligament arteriosum. Midaortic syn‐
drome (MAS) is a rare condition characterized by coarctation of the abdominal aorta or distal 
descending thoracic aorta and thought to arise from an embryonic development disorder [2]. 
It is essential to differentiate MAS such as involvement of the abdominal aorta from other 
causes in large‐vessel vasculitis. In addition to idiopathic MAS, the association of MAS with 
neurofibromatosis, FMD, mucopolysaccharidosis, Alagille syndrome, and William's syn‐
drome could be a genetic etiology. Others include tuberous sclerosis, retroperitoneal fibrosis, 
moyamoya disease, congenital rubella syndrome, epidermal nevus syndrome, and autosomal 
dominant supravalvar aortic stenosis syndrome [11, 12]. The most common anatomic type of 
MAS is suprarenal (60%), followed by intrarenal (25%) and infrarenal (15%) (Figure 4).
Figure 2. Fibromuscular dysplasia. (A) String‐of‐beads appearance in bilateral external iliac arteries (arrows). (B) Multiple 
string‐of‐beads appearances in the left crural artery (arrows).
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Figure 3. Adventitial cystic disease. (A) A 70‐year‐old male presenting moderate claudication. Enhanced CT shows focal 
stenosis in the midsegment of the right popliteal artery (arrow). (B) Ultrasonography revealed a low‐echoic cystic lesion 
along the vessel wall causing significant stenosis in the popliteal artery (arrows). (C) Angiography could confirm focal 
stenosis in the right popliteal artery (arrow).
Figure 4. Idiopathic midaortic syndrome. A 51‐year‐old male presenting renovascular hypertension. Although the 
ABI was 0.70/0.67 (right/left), intermittent claudication was absent. (A) Enhanced CT showing suprarenal abdominal 
aortic coarctation below the origin of the superior mesenteric artery (arrow). (B) Lateral view demonstrates Winslow's 
pathway which is a collateral vessel developing from the subclavian arteries, internal thoracic (mammary) arteries, 
superior epigastric arteries, inferior epigastric arteries into the external iliac arteries (arrows). (C) Anteroposterior view 
AP view reveals the Arc of Riolan which is a mesenteric meandering artery between the superior and inferior mesenteric 
arteries (arrows).
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It is usually discovered during workups for hypertension in children. Renal vessels, mesen‐
teric vessels, or both may also be affected to varying degrees. According to previous reports, 
if the syndrome is left untreated, the majority of patients will die from complications of 
severe hypertension and ischemia by the age of 40 because of myocardial infarction, heart 
failure, intracranial hemorrhage, or aortic rupture [13, 14]. Recent study suggests that good 
long‐term outcomes of MAS can be obtained by medical management [15]. Intermittent 
claudication might be an uncommon clinical presentation compared to manifestation of 
hypertension.
4. Abnormal external and internal forces
4.1. Endofibrosis
Endofibrosis typically involves the narrowing of the external iliac artery in young athletes 
such as cyclists, runners, triathletes, and skaters [16]. The disorder is characterized by inti‐
mal thickening and subsequent narrowing of the artery by collagen fibers, fibrous tissue, and 
smooth muscle proliferation [17]. The pathogenesis is presumed to involve repetitive vessel 
stretching during extreme hip flexion, external compression by psoas muscle hypertrophy, 
repeated vessel kinking during exercise, and shear stress during high cardiac output. This 
disorder is progressive and may lead to occlusion, frequently occurring (85%) unilaterally 
on the left. In addition to the external iliac artery (85%), the common femoral artery (5%) and 
superficial femoral artery (<5%) can be affected [4]. Since no specific angiographic findings 
are observed, a high clinical suspicion of this disorder is required for diagnosis and proper 
treatment.
4.2. Popliteal artery entrapment
Popliteal artery entrapment can be caused by compression of the popliteal artery in the 
popliteal fossa by adjacent or surrounding musculotendinous structures and ligaments. 
This disorder can occur bilaterally (30–67%) and is predominant in young males, although 
cases of elderly patients up to the age of 70 have been reported [4, 18]. The condition may 
become evident when the popliteal artery is abnormally positioned, or in cases of fibrous 
bands or abnormal muscle insertions or slips. There are six types of entrapment based on 
the anatomical compression of the popliteal artery [1]. Computed tomography (CT) angi‐
ography or magnetic resonance (MR) angiography may be useful techniques for identify‐
ing the structures causing external compression of the artery (Figure 5). Angiography may 
also reveal medial or occasionally lateral displacement of the popliteal artery if it is still 
patent. However, the position of the popliteal artery may be normal if the compression is 
due to the plantaris or popliteus muscles. In addition, pre‐stenotic or post‐stenotic dilata‐
tion can be associated with this disorder (Figure 5). Although popliteal artery narrowing 
induced by extension of the knee and dorsiflexion of the foot may support the diagnosis 
of this condition, there is some concern regarding the potential for false‐positive results 
since popliteal artery compression can occur with active plantar flexion even in healthy 
individuals [19].
Nonatherosclerotic Peripheral Artery Disease
http://dx.doi.org/10.5772/67180
131
4.3. Adductor canal outlet syndrome
Adductor canal outlet syndrome involves the compression of the distal superficial femoral 
artery by the adductor canal. It is most commonly reported in runners and skiers, who pres‐
ent with exercise‐induced intermittent claudication symptoms and paresthesias. Symptoms 
are typically chronic but can progress to occlusion and cause acute limb ischemia due to 
thrombus. This condition may be rare but it is possible relationship to acute intimal injury and 
thrombosis should be considered in order to save limbs that may otherwise be lost [20–22].
4.4. Other conditions
Other conditions including neoplasma, pseudoxanthoma elasticum, and Baker's cyst can 
cause lower limb ischemia [4].
5. Vasospasm
Vasospasm can occur even in the lower extremity arteries. There are a variety of causes, 
including idiopathic or certain vasospastic agents (e.g., ergotamine, cocaine, marijuana, and 
amphetamine) [23, 24]. The characteristic findings of drug‐induced vasospasm are bilateral, 
symmetric, and abrupt narrowing of any segment of a lower limb artery. Vasospasm can be 
resolved by discontinuing the offending drug or administering vasodilators (Figure 6).
Figure 5. Popliteal artery entrapment syndrome. A 30‐year‐old male presenting moderate claudication. (A) Enhanced 
CT revealed tight stenosis and post‐stenotic dilatation in the right popliteal artery (arrow). (B) Horizontal view of the 
CT showing compressed popliteal artery by the surrounding muscle (arrow). (C): Subsequent angiography revealed the 
progression to occlusion (arrows).
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6. Vasculitis
Vasculitis may confuse clinicians since it comprises a heterogeneous group of disorders char‐
acterized by inflammation and necrosis of blood vessels. However, the key to diagnosis when 
considering the possible presence of some type of vasculitis is to employ a multidisciplinary 
approach that involves rheumatologists as well as vascular specialists. Based on the size of 
the arteries involved and the underlying cause, vasculitis can be categorized as large vessel, 
medium vessel, or small vessel. The effects of vascular damage including arterial narrowing, 
thrombosis, or aneurysm formation become prominent over the course of these conditions. 
Invasive angiography is the gold standard for detecting such lesions and can be used to mea‐
sure the trans‐lesional pressure gradient. However, there are some concerns regarding inva‐
sive angiography for vasculitis. First, sheath or catheter insertion may cause vascular injury in 
the presence of active inflammation. Second, the potential exists for hypersensitivity reactions 
to the contrast dye as well as contrast nephropathy and volume overload. Moreover, invasive 
angiography does not provide any information on changes in vasculitis activity.
Takayasu's arteritis and giant cell arteritis (GCA) are typical large‐ and medium‐vessel vas‐
culitis that affect the aorta and its main branches, including the subclavian, carotid, verte‐
bral, renal, mesenteric, and iliac arteries. The affected aortoiliac arteries may cause lower 
limb ischemia. Behcet's disease and Buerger's disease are representative conditions affecting 
various‐sized arteries and venous systems. Medium‐vessel vasculitis mainly comprise poly‐
arteritis nodosa, anti‐neutrophil cytoplasmic antibodies (ANCA)‐related vasculitis (granulo‐
matosis with polyangiitis (GPA), microscopic polyangiitis, and eosinophilic granulomatosis 
with polyangiitis), and Kawasaki disease. Assessment of the patient's clinical background 
and systemic examination are indispensable for the diagnosis of this vasculitis. They can also 
potentially emerge in an atypical vascular bed for each disorder, mimicking other types of 
vasculitis [25].
Figure 6. Idiopathic vasospasm (Ref. 24). A 28‐year‐old male presenting claudication with subsequent acute limb 
ischemia. (A) Diagnostic enhanced CT angiogram showing tight narrowings in the bilateral femoropopliteal segments 
(large arrows) and disruptions in the bilateral anterior tibial arteries (small arrows). Also, the proximal segment in the 
superficial femoral artery seems to be spastic. (B) After initiation of medical treatment during hospitalization, complete 
recovery of the disruptive lesions is observed though the crural arteries are superimposed on the veins.




This inflammatory vasculitis of large and medium elastic arteries, also called nonspecific 
aortitis, is characterized pathologically by giant cell infiltration and granuloma formation. 
Destruction of the entire vascular wall and progressive adventitial fibrosis can cause stenosis 
or dilatation that can be complicated with superimposed calcification at the chronic stage. This 
disorder is typically but not exclusively observed in young women of Asian or Latin descent. 
It primarily affects the aorta, its major branches, and the pulmonary arteries, including but 
not limited to the brachiocephalic, carotid (common carotid), vertebral, subclavian (proximal 
subclavian), renal, iliac, femoral, and coronary arteries. Clinically, it usually first presents in 
the second or third decade, but can occur at older ages. Many patients initially complain of 
fever, arthralgias, and malaise. Although the most common symptom of TA is arm claudica‐
tion, observed in greater than 60% of cases, aortoiliac artery involvement can result in lower 
limb ischemic symptoms, and even the femoral artery may be involved [26, 27].
There are no serological tests to identify TA. The diagnosis of TA is based on clinical findings 
in the presence of compatible vascular imaging abnormalities (Table 1) [1].
Angiography can reveal the extent of luminal narrowing, with or without dilatation/aneu‐
rysm, in order to differentiate TA from other diseases. While CT angiography or MR angiog‐
raphy can provide the whole image alternative to angiography, measurement of the pressure 
gradients is one of the major advantages of invasive angiography (Figure 7). It can also provide 
opportunities for surgical or endovascular intervention. However, in terms of evaluating vessel 
wall thickening and edema, duplex US, CT, and MR are more informative than angiography.
6.2. Giant cell arteritis
Although giant cell arteritis is pathologically similar to TA, this type of vasculitis commonly 
affects the temporal artery. The disorder is observed in men and women of around 50 and older, 
and is particularly prevalent in patients aged 70 and older. The arteries potentially affected 
include the aorta and its branches, with a predilection for the distal subclavian,  axillary, and 
proximal brachial arteries, as well as the branches of the carotid arteries, in  particular the oph‐
thalmic artery. Therefore, headaches, jaw claudication, and visual impairment can occur in addi‐
tion to arm claudication. Also, a normal erythrocyte sedimentation rate (ESR) is more useful in 
excluding giant cell arteritis than an elevated ESR is in diagnosing this disease [1] (Table 2).
1990 criteria for the classification of Takayasu arteritis
1. Age at disease onset <40 years
2. Claudication of extremities
3. Decreased brachial artery pulse
4. Difference of >10 mmHg in systolic blood pressure between arms
5. Bruit over subclavian arteries or abdominal aorta
6. Arteriogram abnormality (arteriographic narrowing or occlusion of the entire aorta, its primary branches, or large 
arteries in the proximal upper or lower extremities, not due to arteriosclerosis, fibromuscular dysplasia, or similar 
causes; changes usually focal or segmental)
Takayasu arteritis is defined clinically if at least three of these six criteria are present. The presence of any three or more 
criteria yields a sensitivity of 90.5% and a specificity of 97.8%.
Table 1. American College of Rheumatology diagnostic criteria for Takayasu arteritis.
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Figure 7. Takayasu arteritis. A 20‐year‐old female presenting mild claudication and renovascular hypertension. Invasive 
angiography revealed significant stenosis in the descending thoracic aorta (arrow). The pullback pressure gradient was 
20 mmHg.
1990 criteria for the classification of giant cell arteritis
1. Age at disease onset <50 years
2. New headache
3. Temporal artery abnormality
4. Elevated erythrocyte sedimentation rate
5. Abnormal artery biopsy (biopsy specimen with artery showing vasculitis characterized by a predominance of 
mononuclear cell infiltration or granulomatous inflammation, usually with multinucleated giant cells)
Giant cell arteritis is defined clinically if at least three of these five criteria are present. The presence of any three or more 
criteria yields a sensitivity of 93.5% and a specificity of 91.2%.
Table 2. American College of Rheumatology diagnostic criteria for giant cell arteritis.
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Lower limb arteries can also be affected by this disorder [28, 29]. According to positron emis‐
sion tomography scan studies, the iliac artery was involved in 37% of cases and the femoral 
artery in 37% (subclavian artery 70%, axillary artery 40%) [30]. Other studies have reported 
that superficial femoral artery was involved in 33%, common femoral artery in 14%, internal 
iliac artery 11%, deep femoral artery in 6%, and popliteal artery in 6% of cases [4, 31–34]. 
US studies have also detected the involvement of distal lower limb arteries such as the 
 femoropopliteal, tibial, and peroneal arteries [35]. It is sometimes challenging to differentiate 
lesions from atherosclerosis in older patients.
Findings of arteritis from a temporal artery biopsy can be supportive but not essential for a 
diagnosis. An accurate diagnosis of GCA requires a comprehensive approach that includes 
assessment of clinical manifestations, physical examination, laboratory studies, vascular 
imaging, and arterial biopsies. Positive temporal artery biopsies can occasionally be seen in 
other types of arteritis and the ESR may be normal in up to 10% of GCA patients so that 
cautious interpretation is required. Differential diagnosis of GCA should include brain dis‐
ease, infectious disease, and malignant disease. It should be noted that other vasculitis such 
as polyarteritis nodosa or ANCA‐related vasculitis may rarely present with temporal artery 
involvement. Polymyalgia rheumatic may also be included in this group of vasculitis as it is 
often regarded as one clinical entity with GCA.
Although angiography can confirm the extent of affected vessels, less invasive tools such 
as duplex US, CT angiography, and MR angiography should also be considered. In par‐
ticular, CT is informative for the extent of calcification. The advantage of angiography is 
that it allows measurements of pressure gradients to identify hemodynamically signifi‐
cant lesions.
6.3. Behcet's disease
Vasculitis is observed in less than one‐third of Behcet's disease cases. The etiology remains 
unclear and may involve both genetic and environmental factors. It can potentially be charac‐
terized by concomitant oral and genital ulcerations, skin lesions, uveitis, central nervous sys‐
tem, and gastrointestinal involvement. Approximately 80% of Behcet's disease patients have 
the human leukocyte antigen (HLA)‐B51 allele. However, since no symptoms or laboratory 
findings are pathognomonic for Behcet's disease, diagnosis depends on the patient meeting 
a set of established clinical criteria. The major histopathological features of this disorder are 
predominantly perivascular inflammatory infiltrates and a tendency to thrombus formation 
in both veins and arteries of every size. In particular, venous disease is characteristic, includ‐
ing superficial phlebitis, varices, and thrombosis of the deep veins, vena cava, and cerebral 
sinuses. Large vessels frequently show luminal narrowing, aneurysm, or rupture. Medium 
and small vessels may also be affected [36, 37] (Figure 8).
6.4. Buerger's disease
Buerger's disease, also known as thromboangiitis obliterans (TAO), was first reported by 
Winiwarter in 1879, and later described in detail by Buergers in 1908 [38, 39]. Although the eti‐
ology remains unclear, this disorder is a segmental inflammatory disease typically affecting 
small‐ to medium‐sized arteries of the upper and lower extremities, with occasional  extension 
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to the veins and nerves of the extremities [40–42]. Atypically, multiple large vessels can be 
affected [43]. This condition is more common in men than in women and is almost exclu‐
sively observed in patients who use tobacco so that it is widely recognized that tobacco is 
associated with the onset, progression, and recurrence of the disease. Symptoms can include 
claudication, rest pain, and ischemic tissue loss such as ulceration and gangrene. Unlike other 
vasculitis, inflammatory markers such as the ESR and C‐reactive protein are typically normal. 
Angiography is often required to evaluate lesion extent and runoff conditions since there is the 
potential for over‐ or underestimation of the lesion with MR and CT imaging. Angiographic 
findings include segmental arterial occlusions of small‐ and medium‐sized vessels while large 
arteries are typically spared (Figure 9) [44].
Figure 8. Behcet's disease. A 64‐year‐old male with a history of deep vein thrombosis and cerebral vein thrombosis 
presenting acute onset of rest pain and claudication in the right leg. Invasive angiography revealed right femorocrural 
occlusion. The proximal crural artery was reconstituted through the collateral vessels (arrows).
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The term “corkscrew” has recently been used to describe the appearance of collateral vessels 
in Buerger's disease patients. However, the original article attributes the corkscrew appear‐
ance to the recanalization of the affected native artery [45, 46]. Moreover, the corkscrew 
appearance is not pathognomonic for Buerger's disease as it may be seen in patients with 
other disorders including connective tissue disease. Thus, several different criteria have been 
proposed for the diagnosis of Buerger's disease (Tables 3 and 4) [40, 41].
Figure 9. Buerger's disease. (A) Femorocrural occlusion beyond the right knee joint in a 38‐year‐old female presenting 
foot gangrene. (Ref. 44). (B) Crural artery occlusion in a 37‐year‐old male presenting right toe gangrene. Long total 
occlusions in the tibial arteries extending to the pedal arch.
• History of smoking
• Onset before age 50
• Infrapopliteal arterial occlusions
• Either arm involvement or phlebitis migrans
• Absence of atherosclerotic risk factors other than smoking
Table 3. Criteria of Buerger's disease by Shionoya [40].
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6.5. Other vasculitides
Other rare diseases, including Cogan's syndrome and relapsing polychondritis, can cause 
vasculitis of large‐ or medium‐sized vessels. Small‐vessel vasculitides include cryoglobulin‐
emic vasculitis, leukocytoclastic vasculitides such as Henoch‐Schonlein purpura and isolated 
cutaneous leukocytoclastic vasculitis, and vasculitis secondary to systemic autoimmune dis‐
ease, including rheumatoid arthritis, systemic lupus erythematosus (SLE), and scleroderma 
[30, 47]. It is worth noting that there is the possibility of atypical lesion distribution for any 
type of vasculitides (Figures 10 and 11).
• Age under 45
• Current or recent history of tobacco use
• Presence of distal extremity ischemia as indicated by claudication, pain at rest, ischemic ulcers, or gangrene, and 
documented by noninvasive vascular testing
• Exclusion of autoimmune diseases, hypercoagulable states, and diabetes mellitus
• Exclusion of a proximal source of emboli by echocardiography or arteriography
• Consistent arteriographic findings in the clinically involved and noninvolved limbs
Table 4. Criteria of Buerger's disease by Olin [41].
Figure 10. Systemic lupus erythematosus A 16‐year‐old female presenting claudication with subsequent acute limb 
ischemia as an initial clinical manifestation. Enhanced CT revealed severe femorocrural occlusion. Although the mid‐
tibial arteries were reconstituted, the distal tibial and pedal arteries were occluded.
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For example, there have been case reports of large‐ or medium‐vessel vasculitis in patients 
with rheumatoid arthritis, SLE and ANCA‐related vasculitis [30, 47–62], and uncommon dis‐
eases including hypereosinophilic syndrome, Kimura disease, and angiolymphoid hyperpla‐
sia with eosinophilia can also mimic Buerger's disease [63–65]. Moreover, antiphospholipid 
syndrome (APS) can occur concomitantly with vasculitis secondary to systemic autoimmune 
disease (frequently SLE), and can develop into catastrophic APS [66–73] (Figure 10). Certain 
kinds of vasculitis can be complicated by thrombosis and potentially develop into throm‐
botic storm which has a devastating clinical course [74–77]. Radiation arteritis can occur years 
after high‐dose radiotherapy for pelvic malignant disease. In such cases, stenotic or occlusive 
disease can be seen within the radiation field. Thus, with typical and atypical cases in mind, 
a careful diagnostic workup is vital for vasculitis.
Figure 11. Scleroderma. An 80‐year‐old female presenting toe gangrene with a history of scleroderma. Invasive 
angiography showing multiple stenosis in the right crural artery.
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7. Arterial thrombophilias
There are inherited and acquired disorders in which thrombosis develops in the arterial sys‐
tem. Inherited disorders include hyperhomocysteinemia/hyperhomocystinuria, antithrombin 
deficiency, protein S deficiency, and protein C deficiency, as well as gene polymorphisms 
such as Factor V Leiden. Acquired disorders are more common and can be caused by APS, 
malignancies, hormone therapy, and such myeloproliferative disorders as polycythemia vera, 
thrombocythemia, heparin‐induced thrombocytopenia, and thrombotic thrombocytopenic 
purpura (Figure 12) [78].
Thrombosis can be seen in vasculitis [74, 79]. In particular, inflammation‐induced thrombosis 
is considered to be a feature of certain kinds of vasculitis (systemic autoimmune diseases such 
as SLE, rheumatoid arthritis, and Sjogren's syndrome, and other vasculitis). Thus, primary 
or secondary APS concomitant with autoimmune diseases such as SLE can cause thrombosis 
and potentially develop into catastrophic APS [80–82].
Figure 12. Primary antiphospholipid syndrome [78]. A 75‐year‐old female presenting symmetric peripheral gangrene in 
four limbs. Angiography shows the occlusions in the pedal arteries as well as the palmar arteries due to antiphospholipid 
syndrome.




Congenital malformations of the iliofemoral arterial system are rare, but accurate diagnosis is 
essential to avoid unnecessary revascularization treatment. Congenital absence or hypoplasty 
of the common iliac artery, external iliac artery, and SFA has been reported [83, 84]. Congenital 
variants of the external iliac artery have been classified into three groups [85]: group 1, anomalies 
in the origin or course of the artery; group 2, hypoplasia or atresia compensated for by persistent 
sciatic artery (PSA); and group 3, isolated hypoplasia or atresia. Although group 1 may not be 
associated with lower limb ischemia and is most often discovered at autopsy, group 2, the so‐
called persistent sciatic artery, and group 3 are most likely to present with lower limb ischemia.
Above all, PSA is a popular variant. Failure of regression of the sciatic artery during fetal devel‐
opment is often associated with superficial femoral artery hypoplasia, and the PSA then provides 
the dominant arterial inflow to the lower limb. Therefore, there is continuation of the internal 
iliac artery into the thigh through the greater sciatic notch. This variant can cause not only acute 
lower limb ischemia due to thromboembolism but also chronic lower limb ischemia, with a high 
incidence of aneurysm formation and arteriosclerosis of the sciatic artery (Figure 13) [4, 86].
Figure 13. Persistent sciatic artery. (A, B) A 64‐year‐old male. Enhanced CT incidentally found persistent sciatic artery 
(large arrows) in the right. The right external iliac artery connects with the hypoplastic superficial femoral artery (small 
arrows). (C) A 60‐year‐old female presenting acute limb ischemia. The left external iliac artery connects with the hypoplastic 
superficial femoral artery whereas the persistent sciatic artery through the left internal iliac artery is the dominant blood 
supply (small arrows). The distal part of the sciatic artery is occluded due to thromboembolism (large arrow).
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9. Embolism
Embolism can potentially cause manifestations of chronic lower limb ischemia, such as clau‐
dication and critical limb ischemia, but not acute limb ischemia in particular in the elderly 
population. Embolisms may have a number of sources including cardiac, aortic, and right‐to‐
left shunts (paradoxical embolism from the venous circulation).
10. Vascular injury
Orthopedic surgery or trauma may cause lower limb ischemia because of dissection or throm‐
botic occlusion [87]. Additionally, pediatric cardiac catheterization using the transfemoral 
approach could be a cause of iliofemoral occlusion or stenosis due to thrombosis formation 
or intimal hyperplasia (Figure 14). This disorder may be asymptomatic until adulthood, but 
long‐term uncorrected circulatory impairment can potentially cause limb growth retardation 
even in the absence of symptomatic evidence of ischemia [88–93].
Figure 14. Vascular injury following catheterization. A 4‐year‐old boy experienced a pale foot on the right following 
catheterization. Enhanced CT revealed a short occlusion due to puncture site thrombosis in the proximal segment of the 
right superficial femoral artery (arrows).




This section is intended to focus on vascular imaging, mainly invasive angiography, for 
NAPAD. From a clinical standpoint, an increase in opportunities to experience the symptoms 
and signs of APAD heightens the importance of the differential diagnosis of NAPAD in daily 
practice. NAPAD cannot benefit from a one‐size‐fits‐all approach compared to APAD. Thus, 
differentiation between NAPAD and APAD may be a challenging task but we clinicians need 
to increase our knowledge of the diversity of NAPAD so that such awareness can be trans‐
lated into improved patient care.
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